LucidScope
AI is already answering questions about your brand. LucidScope shows you what it’s saying, and why.
LucidScope evaluates how leading AI systems respond to real-world questions about your company, products, indications, and competitors.
It maps visibility and positioning in AI-generated answers, traces the sources shaping those answers, and highlights gaps where evidence is missing, outdated, or misrepresented.
What you can do with LucidScope:
-
Perception Mapping: Compare how AI positions your brand versus key competitors.
- See how AI frames your brand versus competitors, by theme and attribute.
-
Answers Mapping: See how models answer the same stakeholder questions, and where they diverge.
- View side-by-side model answers to your key questions, with differences highlighted.
-
Source Tracing: Identify which websites and documents are shaping AI answers, and where to intervene.
- Understand which domains and documents drive the answers, and what’s missing.
-
Launch and campaign monitoring: Track changes over time across models, markets, and topics.
- Monitor shifts in positioning, key claims, and cited sources (you vs competitors).
Want to see what AI is saying about your brand? Request an AI Answer Audit.
You’ll receive a short report covering Perception, Answers, Source Tracing, and Zero-click gaps.
Already evaluating tools? Test LucidScope.
Questions or feedback? Email us anytime.
November 20, 2025
Cell and Gene Therapy Today—November 20, 2025
November 19, 2025
Neuroscience Today — November 19, 2025
November 19, 2025
Immunology Video Recap—November 19, 2025
November 19, 2025
Immunology Today—November 19, 2025
November 19, 2025
Lucid Diligence Brief: Avanzanite Bioscience €32m Series A
November 18, 2025
AI in Healthcare and Digital Health Video Recap—November 18, 2025
November 18, 2025
Obesity Today—November 18, 2025
November 18, 2025
Endocrinology Video Recap—November 18, 2025
November 18, 2025
Endocrinology Today—November 18, 2025
November 18, 2025
Lucid Diligence Brief: Johnson & Johnson acquires Halda Therapeutics
November 17, 2025